What is a stock summary page? Click here for an overview.
Business Description
QuidelOrtho Corp
NAICS : 339112
SIC : 5047
ISIN : US2197981051
Share Class Description:
LTS:0A55: Ordinary SharesDescription
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to makeĀ decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.9 | |||||
| Debt-to-EBITDA | -1.8 | |||||
| Interest Coverage | 0.24 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -0.08 | |||||
| Beneish M-Score | -2.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.5 | |||||
| 3-Year EPS without NRI Growth Rate | -52 | |||||
| 3-Year Book Growth Rate | -1.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 33.96 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 2.13 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.92 | |||||
| 9-Day RSI | 46.43 | |||||
| 14-Day RSI | 48.85 | |||||
| 3-1 Month Momentum % | -1.96 | |||||
| 6-1 Month Momentum % | -4.16 | |||||
| 12-1 Month Momentum % | -10.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.22 | |||||
| Quick Ratio | 0.69 | |||||
| Cash Ratio | 0.1 | |||||
| Days Inventory | 140.18 | |||||
| Days Sales Outstanding | 37.3 | |||||
| Days Payable | 62.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.3 | |||||
| Shareholder Yield % | -0.39 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.23 | |||||
| Operating Margin % | 1.65 | |||||
| Net Margin % | -73.74 | |||||
| FCF Margin % | -4.03 | |||||
| ROE % | -58.1 | |||||
| ROA % | -29.16 | |||||
| ROIC % | 0.68 | |||||
| 3-Year ROIIC % | -15.02 | |||||
| ROC (Joel Greenblatt) % | -99.97 | |||||
| ROCE % | -31.74 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 18.26 | |||||
| PE Ratio without NRI | 18.86 | |||||
| Shiller PE Ratio | 12.58 | |||||
| PS Ratio | 0.84 | |||||
| PB Ratio | 0.79 | |||||
| Price-to-Operating-Cash-Flow | 28.44 | |||||
| EV-to-EBIT | -2.54 | |||||
| EV-to-Forward-EBIT | 12.92 | |||||
| EV-to-EBITDA | -3.31 | |||||
| EV-to-Forward-EBITDA | 8.34 | |||||
| EV-to-Revenue | 1.77 | |||||
| EV-to-Forward-Revenue | 1.8 | |||||
| EV-to-FCF | -44.03 | |||||
| Price-to-GF-Value | 0.73 | |||||
| Price-to-Projected-FCF | 0.34 | |||||
| Price-to-Median-PS-Value | 0.23 | |||||
| Earnings Yield (Greenblatt) % | -39.37 | |||||
| FCF Yield % | -4.76 | |||||
| Forward Rate of Return (Yacktman) % | 44.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Ā
Total Annual Return % Ā
QuidelOrtho Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2,782.9 | ||
| EPS (TTM) ($) | -30.28 | ||
| Beta | 1.12 | ||
| 3-Year Sharpe Ratio | -0.56 | ||
| 3-Year Sortino Ratio | -0.67 | ||
| Volatility % | 46.3 | ||
| 14-Day RSI | 48.85 | ||
| 14-Day ATR ($) | 0.065989 | ||
| 20-Day SMA ($) | 43.5 | ||
| 12-1 Month Momentum % | -10.25 | ||
| 52-Week Range ($) | 29.91 - 48.5425 | ||
| Shares Outstanding (Mil) | 67.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
QuidelOrtho Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
QuidelOrtho Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
QuidelOrtho Corp Frequently Asked Questions
What is QuidelOrtho Corp(LTS:0A55)'s stock price today?
The current price of LTS:0A55 is $43.50. The 52 week high of LTS:0A55 is $48.54 and 52 week low is $29.91.
When is next earnings date of QuidelOrtho Corp(LTS:0A55)?
The next earnings date of QuidelOrtho Corp(LTS:0A55) is 2025-05-08 Est..
Does QuidelOrtho Corp(LTS:0A55) pay dividends? If so, how much?
QuidelOrtho Corp(LTS:0A55) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers